Chargement en cours...
Pneumococcal Vaccination in Adults Aged ≥65 Years: Cost Effectiveness and Health Impact in U.S. Populations
INTRODUCTION: Recommending both the conjugate and polysaccharide pneumococcal vaccines to all U.S. seniors may have little public health impact and be economically unreasonable. Public health impact and cost effectiveness of using both vaccines in all adults aged ≥65 years were estimated compared wi...
Enregistré dans:
| Publié dans: | Am J Prev Med |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7089827/ https://ncbi.nlm.nih.gov/pubmed/32001052 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amepre.2019.10.022 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|